1. Home
  2. OPK vs REAL Comparison

OPK vs REAL Comparison

Compare OPK & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • REAL
  • Stock Information
  • Founded
  • OPK 2007
  • REAL 2011
  • Country
  • OPK United States
  • REAL United States
  • Employees
  • OPK N/A
  • REAL N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • REAL Other Specialty Stores
  • Sector
  • OPK Health Care
  • REAL Consumer Discretionary
  • Exchange
  • OPK Nasdaq
  • REAL Nasdaq
  • Market Cap
  • OPK 989.0M
  • REAL 1.2B
  • IPO Year
  • OPK 1995
  • REAL 2019
  • Fundamental
  • Price
  • OPK $1.50
  • REAL $9.46
  • Analyst Decision
  • OPK Strong Buy
  • REAL Buy
  • Analyst Count
  • OPK 3
  • REAL 6
  • Target Price
  • OPK $2.75
  • REAL $7.04
  • AVG Volume (30 Days)
  • OPK 2.5M
  • REAL 3.6M
  • Earning Date
  • OPK 02-25-2025
  • REAL 02-27-2025
  • Dividend Yield
  • OPK N/A
  • REAL N/A
  • EPS Growth
  • OPK N/A
  • REAL N/A
  • EPS
  • OPK N/A
  • REAL N/A
  • Revenue
  • OPK $711,408,000.00
  • REAL $579,862,000.00
  • Revenue This Year
  • OPK N/A
  • REAL $11.26
  • Revenue Next Year
  • OPK $0.00
  • REAL $8.81
  • P/E Ratio
  • OPK N/A
  • REAL N/A
  • Revenue Growth
  • OPK N/A
  • REAL 2.52
  • 52 Week Low
  • OPK $0.86
  • REAL $1.52
  • 52 Week High
  • OPK $1.76
  • REAL $11.38
  • Technical
  • Relative Strength Index (RSI)
  • OPK 45.83
  • REAL 54.76
  • Support Level
  • OPK $1.46
  • REAL $7.89
  • Resistance Level
  • OPK $1.50
  • REAL $10.00
  • Average True Range (ATR)
  • OPK 0.05
  • REAL 0.69
  • MACD
  • OPK 0.00
  • REAL -0.14
  • Stochastic Oscillator
  • OPK 37.50
  • REAL 45.74

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.

Share on Social Networks: